The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents
Open accessAbstract
Drug discovery relies on the knowledge of not only drugs and targets, but also the comparative agents and targets. These include poor binders and non-binders for developing discovery tools, prodrugs for improved therapeutics, co-targets of therapeutic targets for multi-target strategies and off-target investigations, and the collective structure-activity and drug-likeness landscapes of enhanced drug feature. However, such valuable data are inadequately covered by the available databases. In this study, a major update of the Therapeutic Target Database, previously featured in NAR, was therefore introduced. This update includes (a) 34 861 poor binders and 12 683 non-binders of 1308 targets; (b) 534 prodrug-drug pairs for 121 targets; (c) 1127 co-targets of 672 targets regulated by 642 approved and 624 clinical trial drugs; (d) the collective structure-activity landscapes of 427 262 active agents of 1565 targets; (e) the profiles of drug-like properties of 33 598 agents of 1102 targets. Moreover, a variety of additional data and function are provided, which include the cross-links to the target structure in PDB and AlphaFold, 159 and 1658 newly emerged targets and drugs, and the advanced search function for multi-entry target sequences or drug structures. The database is accessible without login requirement at: https://idrblab.org/ttd/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Database resources of the National Center for Biotechnology Information: update
Wheeler, D. L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh073 · Cited by 10,641
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051256o · Cited by 6,851
UniProt: the universal protein knowledgebase in 2021
The UniProt Consortium, Bateman, A., Martin, M.-J., Orchard, S., Magrane, M., Agivetova, R., Ahmad, S., Alpi, E., Bowler-Barnett, E. H., Britto, R., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1100 · Cited by 6,372
Self-citationLead- and drug-like compounds: the rule-of-five revolution
Lipinski, C. A. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.11.007 · Cited by 6,199
PubChem in 2021: new data content and improved web interfaces
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa971 · Cited by 3,953
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Bostock, M., Ogievetsky, V., & Heer, J. (2011) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2011.185 · Cited by 3,165
Highly accurate protein structure prediction for the human proteome
Tunyasuvunakool, K., Adler, J., Wu, Z., Green, T., Zielinski, M., Žídek, A., Bridgland, A., Cowie, A., Meyer, C., Laydon, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03828-1 · Cited by 3,025
PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints
Yap, C. W. (2011) · Journal of Computational Chemistry · doi:10.1002/jcc.21707 · Cited by 2,962
Ligand docking and binding site analysis with PyMOL and Autodock/Vina
Seeliger, D., & de Groot, B. L. (2010) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-010-9352-6 · Cited by 2,623
A comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
A Critical Assessment of Docking Programs and Scoring Functions
Warren, G. L., Andrews, C. W., Capelli, A.-M., Clarke, B., LaLonde, J., Lambert, M. H., Lindvall, M., Nevins, N., Semus, S. F., Senger, S., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050362n · Cited by 1,814
Burley, S. K., Bhikadiya, C., Bi, C., Bittrich, S., Chen, L., Crichlow, G. V., Christie, C. H., Dalenberg, K., Di Costanzo, L., Duarte, J. M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1038 · Cited by 1,581
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0224-x · Cited by 1,573
Database resources of the National Center for Biotechnology Information
Sayers, E. W., Beck, J., Bolton, E. E., Bourexis, D., Brister, J. R., Canese, K., Comeau, D. C., Funk, K., Kim, S., Klimke, W., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa892 · Cited by 962
Large-scale prediction and testing of drug activity on side-effect targets
Lounkine, E., Keiser, M. J., Whitebread, S., Mikhailov, D., Hamon, J., Jenkins, J. L., Lavan, P., Weber, E., Doak, A. K., Côté, S., et al. (2012) · Nature · doi:10.1038/nature11159 · Cited by 881
3D-QSAR in Drug Design - A Review
Verma, J., Khedkar, V., & Coutinho, E. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790232260 · Cited by 830
Wang, Y., Zhang, S., Li, F., Zhou, Y., Zhang, Y., Wang, Z., Zhang, R., Zhu, J., Ren, Y., Tan, Y., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz981 · Cited by 794
Self-citationThe expanding role of prodrugs in contemporary drug design and development
Rautio, J., Meanwell, N. A., Di, L., & Hageman, M. J. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.46 · Cited by 767
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Lin, A., Giuliano, C. J., Palladino, A., John, K. M., Abramowicz, C., Yuan, M. L., Sausville, E. L., Lukow, D. A., Liu, L., Chait, A. R., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw8412 · Cited by 754
An open-source drug discovery platform enables ultra-large virtual screens
Gorgulla, C., Boeszoermenyi, A., Wang, Z.-F., Fischer, P. D., Coote, P. W., Padmanabha Das, K. M., Malets, Y. S., Radchenko, D. S., Moroz, Y. S., Scott, D. A., et al. (2020) · Nature · doi:10.1038/s41586-020-2117-z · Cited by 641
Li, Y. H., Yu, C. Y., Li, X. X., Zhang, P., Tang, J., Yang, Q., Fu, T., Zhang, X., Cui, X., Tu, G., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1076 · Cited by 523
Self-citationPrediction of protein function from protein sequence and structure
Whisstock, J. C., & Lesk, A. M. (2003) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583503003901 · Cited by 460
MIENTURNET: an interactive web tool for microRNA-target enrichment and network-based analysis
Licursi, V., Conte, F., Fiscon, G., & Paci, P. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3105-x · Cited by 401
Exploring Activity Cliffs in Medicinal Chemistry: Miniperspective
Stumpfe, D., & Bajorath, J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201706b · Cited by 374
ChemmineR: a compound mining framework for R
Cao, Y., Charisi, A., Cheng, L.-C., Jiang, T., & Girke, T. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn307 · Cited by 374
NOREVA: normalization and evaluation of MS-based metabolomics data
Li, B., Tang, J., Yang, Q., Li, S., Cui, X., Li, Y., Chen, Y., Xue, W., Li, X., & Zhu, F. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx449 · Cited by 352
Self-citationXue, W., Yang, F., Wang, P., Zheng, G., Chen, Y., Yao, X., & Zhu, F. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00490 · Cited by 288
Self-citationBender, A., & Cortes-Ciriano, I. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.11.037 · Cited by 232
Yang, Q., Li, B., Tang, J., Cui, X., Wang, Y., Li, X., Hu, J., Chen, Y., Xue, W., Lou, Y., et al. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz049 · Cited by 217
Self-citationAn omics perspective on drug target discovery platforms
Paananen, J., & Fortino, V. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz122 · Cited by 207
Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., Sharman, J. L., Campo, B., Cavanagh, D. R., Alexander, S. P. H., Davenport, A. P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz951 · Cited by 191
DrugCentral 2021 supports drug discovery and repositioning
Avram, S., Bologa, C. G., Holmes, J., Bocci, G., Wilson, T. B., Nguyen, D.-T., Curpan, R., Halip, L., Bora, A., Yang, J. J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa997 · Cited by 189
NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data
Yang, Q., Wang, Y., Zhang, Y., Li, F., Xia, W., Zhou, Y., Qiu, Y., Li, H., & Zhu, F. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa258 · Cited by 186
Self-citationTarget-Based Evaluation of “Drug-Like” Properties and Ligand Efficiencies
Leeson, P. D., Bento, A. P., Gaulton, A., Hersey, A., Manners, E. J., Radoux, C. J., & Leach, A. R. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00416 · Cited by 176
Tang, J., Fu, J., Wang, Y., Li, B., Li, Y., Yang, Q., Cui, X., Hong, J., Li, X., Chen, Y., et al. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bby127 · Cited by 168
Self-citationLi, Y., Li, X. X., Hong, J. J., Wang, Y., Fu, J., Yang, H. J., Yu, C. Y., Li, F., Hu, J., Xue, W., et al. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby130 · Cited by 162
Self-citationDrug discovery effectiveness from the standpoint of therapeutic mechanisms and indications
Shih, H.-P., Zhang, X., & Aronov, A. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.194 · Cited by 160
Shen, W. X., Zeng, X. L., Zhu, F., Wang, Y. L., Chu, Q., Tan, Y. C., Jiang, Y. Y., & Chen, Y. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-021-00301-6 · Cited by 160
Self-citationXue, Y., Li, Z. R., Yap, C. W., Sun, L. Z., Chen, X., & Chen, Y. Z. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci049869h · Cited by 158
Self-citationFrom Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design
Škalič, M., Sabbadin, D., Sattarov, B., Sciabola, S., & Fabritiis, G. D. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00634 · Cited by 153
Hong, J., Luo, Y., Zhang, Y., Ying, J., Xue, W., Xie, T., Tao, L., & Zhu, F. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz081 · Cited by 147
Self-citationVARIDT 1.0: variability of drug transporter database
Yin, J., Sun, W. C., Li, F., Hong, J., Li, X., Zhou, Y., Lu, Y., Liu, M., Zhang, X. Z., Chen, N., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz779 · Cited by 141
Self-citationInhibitory Effects of Silibinin on Cytochrome P‐450 Enzymes in Human Liver Microsomes
Beckmann‐Knopp, S., Rietbrock, S., Weyhenmeyer, R., Böcker, R. H., Beckurts, K. T. E., Lang, W., Hunz, M., & Fuhr, U. (2000) · Pharmacology & Toxicology · doi:10.1111/j.0901-9928.2000.860602.x · Cited by 136
Martínez, A., Alonso, M., Castro, A., Dorronsoro, I., Gelpí, J. L., Luque, F. J., Pérez, C., & Moreno, F. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040895g · Cited by 135
Tracing the origin and evolution of pseudokinases across the tree of life
Kwon, A., Scott, S. T., Taujale, R., Yeung, W., Kochut, K. J., Eyers, P. A., & Kannan, N. (2019) · Science Signaling · doi:10.1126/scisignal.aav3810 · Cited by 127
Hong, J., Luo, Y., Mou, M., Fu, J., Zhang, Y., Xue, W., Xie, T., Tao, L., Lou, Y., & Zhu, F. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz120 · Cited by 117
Self-citationSAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19
Fiscon, G., Conte, F., Farina, L., & Paci, P. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008686 · Cited by 114
Tang, J., Fu, J., Wang, Y., Luo, Y., Yang, Q., Li, B., Tu, G., Hong, J., Cui, X., Chen, Y., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001169 · Cited by 112
Self-citationImidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents
Wu, T., Nagle, A. S., Kuhen, K., Gagaring, K., Borboa, R., Francek, C., Chen, Z., Plouffe, D., Goh, A., Lakshminarayana, S. B., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2003359 · Cited by 103
Deep evolutionary analysis reveals the design principles of fold A glycosyltransferases
Taujale, R., Venkat, A., Huang, L., Zhou, Z., Yeung, W., Rasheed, K., Li, S., Edison, A. S., Moremen, K. W., & Kannan, N. (2020) · eLife · doi:10.7554/elife.54532 · Cited by 102
Fortino, V., Wisgrill, L., Werner, P., Suomela, S., Linder, N., Jalonen, E., Suomalainen, A., Marwah, V., Kero, M., Pesonen, M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009192117 · Cited by 99
INTEDE: interactome of drug-metabolizing enzymes
Yin, J., Li, F., Zhou, Y., Mou, M., Lu, Y., Chen, K., Jia, X., Luo, Y., Fu, J., He, X., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa755 · Cited by 96
Self-citationDrug metabolism and pharmacokinetics in drug discovery.
Roberts, S. A. (2003) · PubMed · Cited by 95
Rella, M., Rushworth, C. A., Guy, J. L., Turner, A. J., Langer, T., & Jackson, R. M. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci0503614 · Cited by 91
Han, L., Ma, X. H., Lin, H., Jia, J., Zhu, F., Xue, Y. W., Li, Z., Cao, Z. W., Ji, Z., & Chen, Y. (2008) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2007.12.002 · Cited by 83
Self-citationSAveRUNNER: an R-based tool for drug repurposing
Fiscon, G., & Paci, P. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04076-w · Cited by 81
VARIDT 1.0: variability of drug transporter database
Yin, J., Sun, W. C., Li, F., Hong, J., Li, X., Zhou, Y., Lu, Y., Liu, M., Zhang, X. Z., Chen, N., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz878 · Cited by 77
Self-citationSSizer: Determining the Sample Sufficiency for Comparative Biological Study
Li, F., Zhou, Y., Zhang, X., Tang, J., Yang, Q., Zhang, Y., Luo, Y., Hu, J., Xue, W., Qiu, Y., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.027 · Cited by 68
Self-citationTao, L., Zhu, F., Xu, F., Chen, Z., Jiang, Y., & Chen, Y. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.09.019 · Cited by 56
Self-citationExploring protein hotspots by optimized fragment pharmacophores
Bajusz, D., Wade, W. S., Satała, G., Bojarski, A. J., Ilaš, J., Ebner, J., Grebien, F., Papp, H., Jakab, F., Douangamath, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23443-y · Cited by 56
PathwayMap: Molecular Pathway Association with Self-Normalizing Neural Networks
Jiménez-Luna, J., Sabbadin, D., Cuzzolin, A., Martínez-Rosell, G., Gora, J., Manchester, J. I., Duca, J. S., & Fabritiis, G. D. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00711 · Cited by 37
A comprehensive integrated drug similarity resource for in-silico drug repositioning and beyond
Azad, A., Dinarvand, M., Nematollahi, A., Swift, J., Lutze-Mann, L. H., & Vafaee, F. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa126 · Cited by 22
Small Molecule Modulation of Intrinsically Disordered Proteins Using Molecular Dynamics Simulations
Herrera-Nieto, P., Pérez, A., & Fabritiis, G. D. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00381 · Cited by 22
Kwon, J., Jeong, H.-W., Kim, H., Kang, K., Chang, Y., Bae, K., Choi, J.-D., Lee, U. C., Son, K., & Kwon, B. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.799 · Cited by 21
Harnessing benefit from targeting tumor associated carbohydrate antigens
Kieber‐Emmons, T., Monzavi‐Karbassi, B., Hutchins, L. F., Pennisi, A., & Makhoul, I. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1264789 · Cited by 16
Huang, L., Yeung, W., Wang, Y., Cheng, H., Venkat, A., Li, S., Ma, P., Rasheed, K., & Kannan, N. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03842-6 · Cited by 16
Yin, J., Li, X., Li, F., Lu, Y., Zeng, S., & Zhu, F. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.04.035 · Cited by 15
Self-citationTeli, M. K., Kumar, S., Yadav, D. K., & Kim, M. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29933 · Cited by 14
Hu, H., & Bajorath, J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112846 · Cited by 13
ThETA: transcriptome-driven efficacy estimates for gene-based TArget discovery
Failli, M., Paananen, J., & Fortino, V. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa518 · Cited by 9
Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening
Kumar, S., Jang, C., Subedi, L., Kim, S. Y., & Kim, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-78077-9 · Cited by 7
Systematic Exploration of Activity Cliffs Containing Privileged Substructures
Hu, H., & Bajorath, J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01236 · Cited by 5
Naveja, J. J., Stumpfe, D., Medina‐Franco, J. L., & Bajorath, J. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00036 · Cited by 2
Cited by
Olson, R. D., Assaf, R., Brettin, T., Conrad, N., Cucinell, C., Davis, J. J., Dempsey, D. M., Dickerman, A., Dietrich, E. M., Kenyon, R. W., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1003 · Cited by 1,260
Self-citationTTD: Therapeutic Target Database describing target druggability information
Zhou, Y., Zhang, Y., Zhao, D., Yu, X., Shen, X., Zhou, Y., Wang, S., Qiu, Y., Chen, Y., & Zhu, F. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad751 · Cited by 645
Self-citationDeep learning in drug discovery: an integrative review and future challenges
Askr, H., Elgeldawi, E., Aboul Ella, H., Elshaier, Y. A. M. M., Gomaa, M. M., & Hassanien, A. E. (2023) · Artificial Intelligence Review · doi:10.1007/s10462-022-10306-1 · Cited by 390
Ren, F., Ding, X., Zheng, M., Korzinkin, M., Cai, X., Zhu, W., Mantsyzov, A., Aliper, A., Aladinskiy, V., Cao, Z., et al. (2023) · Chemical Science · doi:10.1039/d2sc05709c · Cited by 365
AI-powered therapeutic target discovery
Pun, F. W., Ozerov, I. V., & Zhavoronkov, A. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.06.010 · Cited by 341
Metadata
- Authors
- Zhou, Y., Zhang, Y., Lian, X., Li, F., Wang, C., Zhu, F., Qiu, Y., & Chen, Y.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-10-28
- Volume
- 50
- Issue
- D1
- Pages
- D1398-D1407
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W3210331473
- Cited by
- 665
- References
- 79
- FWCI
- 67.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.